In another study, Assaf et al. longitudinally monitored ctDNA at five timepoints in stage IV NSCLC patients treated with anti-PD-L1 combined with chemotherapy and built a machine learning model integrating multiple ctDNA metrics to predict OS [104]. Here, CD274 is linked to non-small cell lung carcinoma.